Dose-related cardiovascular effects of amrinone and epinephrine in reversing bupivacaine-induced cardiovascular depression

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 6, 1998, Pages 698-706

  Igarashi, T ^a   Hirabayashi, Y ^a   Saitoh, K ^a   Fukuda, H ^a   Shimizu, R ^a   Mitsuhata, H ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anesthetics, local: bupivacaine; Anesthetics, volatile: sevoflurane; Catecholamines: epinephrine; Complications: intoxication; Heart, cardiac performance; Phosphodiesterase inhibitors: amrinone

Indexed keywords

ADRENALIN; AMRINONE; BUPIVACAINE; CALTONIC; UNCLASSIFIED DRUG;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; DOG; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HEART ARRHYTHMIA; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; INTRAVENOUS DRUG ADMINISTRATION; LOCAL ANESTHESIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0031806017     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05304.x     Document Type: Article

References (27)

1. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979: 51: 285-287.
2. Lynch C III. Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine. Anesth Analg 1986: 65: 551-559.
3. Moore DC, Scurlock JE. Possible role of epinephrine in prevention or correction of myocardial depression associated with bupivacaine. Anesth Analg 1983: 62: 450-453.
4. De La Coussaye JE, Bassoul B, Brugada J, Albat B, Peray PA, Gagnol JP et al. Reversal of electrophysiologic and hemodynamic effects induced by high dose of bupivacaine by the combination of clonidine and dobutamine in anesthetized dogs. Anesth Analg 1992: 74: 703-711.
5. Lacombe P, Biaise G, Hollmann C, Tanguay M, Loulmet D. Isoproterenol corrects the effects of bupivacaine on the electrophysiologic properties of the isolated rabbit heart. Anesth Analg 1991: 72: 70-74.
6. Heavner JE, Pitkänen MT, Shi B, Rosenberg PH. Resuscitation from bupivacaine-induced asystole in rats: Comparison of different cardioactive drugs. Anesth Analg 1995: 80: 1134-1139.
7. Lindgren L, Randell T, Suzuki N, Kyttä J, Yli-Hankala A, Rosenberg PH. The effect of amrinone on recovery from severe bupivacaine intoxication in pigs. Anesthesiology 1992: 77: 309-315.
8. Saitoh K, Hirabayashi Y, Shimizu R, Fukuda H. Amrinone is superior to epinephrine in reversing bupivacaine-induced cardiovascular depression in sevoflurane anesthetized dogs. Anesthesiology 1995: 83: 127-133.
9. Kambam JR, Kinney WW, Matsuda F, Wright W, Holaday DA. Epinephrine and phenylephrine increase cardiorespiratory toxicity of intravenously administered bupivacaine in rats. Anesth Analg 1990: 70: 543-545.
10. Long W, Rosenblum S, Grady I. Successful resuscitation of bupivacaine-induced cardiac arrest using cardiopulmonary bypass. Anesth Analg 1989: 69: 403-406.
11. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976: 58: 751-760.
12. Pagel PS, Grossman W, Haering JM, Warltier DC. Left ventricular diastolic function in the normal and diseased heart. Perspectives for the anesthesiologist (First of two parts). Anesthesiology 1993: 79: 836-854.
13. Pagel PS, Grossman W, Haering JM, Warltier DC. Left ventricular diastolic function in the normal and diseased heart. Perspectives for the anesthesiologist (Second of two parts). Anesthesiology 1993: 79: 1104-1120.
14. Wiegand UW, Chou RC, Lanz E, Jähnchen E. Determination of bupivacaine in human plasma by high-performance liquid chromatography. J Chromatogr 1984: 311: 218-222.
15. Fujita Y. Amrinone reverses bupivacaine-induced regional myocardial dysfunction. Acta Anaesthesiol Scand 1996: 40: 47-52.
16. Coyle D, Sperelakis N. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle. J Pharmacol Exp Ther 1987: 242: 1001-1005.
17. Feldman HS, Arthur GR, Pikanen M, Hurley R, Doucette AM, Covino BG. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991: 73: 373-384.
18. Heavner JE, Mather L, Pitkänen MT, Shi B. Should epinephrine be used to treat local anesthetic-induced cardiotoxicity? (letter). Anesthesiology 1994: 80: 1179.
19. Kaplan JA, Guffin AV. Treatment of perioperative left ventricular failure. In: Kaplan JA ed. Cardiac anesthesia. 3rd edn. Philadelphia: WB Saunders, 1993: 1058-1094.
20. Freedman MD, Gal G, Freed CR. Extracorporeal pump assistance - novel treatment for acute lidocaine poisoning. Eur J Clin Pharmacol 1982: 22: 129-135.
21. Hotvedt R, Refsum H, Helgesen KG. Cardiac electrophysiologic and hemodynamic effects related to plasma levels of bupivacaine in the dog. Anesth Analg 1985: 64: 388-394.
22. Eledjam JJ, de La Coussaye JE, Brugada J, Masse C, Desh G, D'Athis F et al. Cardiac electrophysiological effects of bupivacaine in the anesthetized dog: relation with plasma concentration. Arch Int Pharmacodyn Ther 1988: 295: 147-156.
23. Tisdale JE, Patel R, Webb CR, Borzak S, Zarowltz BJ. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents. Prog Cardiovasc Dis 1995: 38: 167-180.
24. Kodama I, Kondo N, Shibata S. Effects of amrinone on the transmembrane action of rabbit sinus node pacemaker cells. Br J Pharmacol 1983: 80: 511-517.
25. Piwonka RW, Healey JF, Canniff PC, Farah AE. Electrophysiological actions of amrinone in dogs with cardiac lesions. J Cardiovasc Pharmacol 1983: 5: 1052-1057.
26. Josephson ME. Recurrent ventricular tachycardia. In: Josephson ME, ed. Clinical cardiac electrophysiology - Techniques and interpretations. 2nd edn. Philadelphia: Lea and Febiger, 1993: 417-615.
27. Kullberg MP, Freeman GB, Biddlecome C, Alousi AA, Edelson J. Amrinone metabolism. Clin Pharmacol Ther 1981: 29: 394-401.